Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: A multicentre prospective randomized trial

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages

  Braumann, Chris ^a   Gutt, Carsten N ^b   Scheele, Johannes ^c   Menenakos, Charalambos ^a   Willems, Wilhelm ^a   Mueller, Joachim M ^a   Jacobi, Christoph A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; POVIDONE IODINE; TAUROLIDINE; TAUROLINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; TAURINE; THIADIAZINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; DISTANT METASTASIS; DRUG EFFICACY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; FOLLOW UP; GASTROINTESTINAL TUMOR; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAURINE; THIADIAZINES;

EID: 64949162680     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-32     Document Type: Article

References (29)

1. Sugarbaker PH Mora JT Carmignani P Stuart OA Yoo D Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy Oncologist 2005, 10:112-122. 10.1634/theoncologist.10-2-112 15709213
2. Diaz-Rubio E New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers Oncologist 2004, 9:282-294. 10.1634/ theoncologist.9-3-282 15169983
3. Jacobi CA Wildbrett P Volk T Muller JM Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model Surg Endosc 1999, 13:1021-1025. 10.1007/s004649901160 10526040
4. Braumann C Ordemann J Kilian M Wenger FA Jacobi CA Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy Clin Exp Metastasis 2003, 20:387-394. 10.1023/A:1025402919341 14524527
5. McCourt M Wang JH Sookhai S Redmond HP Taurolidine inhibits tumor cell growth in vitro and in vivo Ann Surg Oncol 2000, 7:685-691. 10.1007/ s10434-000-0685-6 11034247
6. Calabresi P Goulette FA Darnowski JW Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent Cancer Res 2001, 61:6816-6821. 11559556
7. Han Z Ribbizi I Pantazis P Wyche J Darnowski J Calabresi P The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism Anticancer Res 2002, 22:1959-1964. 12174870
8. Stendel R Stoltenburg-Didinger G Al Keikh CL Wattrodt M Brock M The effect of taurolidine on brain tumor cells Anticancer Res 2002, 22:809-814. 12014655
9. Wenger FA Kilian M Braumann C Neumann A Ridders J Peter FJ Guski H Jacobi CA Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer Clin Exp Metastasis 2002, 19:169-173. 10.1023/A:1014579718391 11964081
10. Braumann C Henke W Jacobi CA Dubiel W The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis Int J Cancer 2004, 112:225-230. 10.1002/ijc.20393 15352034
11. Jacobi CA Peter FJ Wenger FA Ordemann J Muller JM New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat. Dig Surg 1999, 16:393-399. 10.1159/000018754 10567800
12. Galland RB Saunders JH Mosley JG Darrell JH Prevention of wound infection in abdominal operations by peroperative antibiotics or povidone-iodine. A controlled trial Lancet 1977, 19(2):1043-1045. 10.1016/S0140-6736(77)91880-3
13. Tsunoda A Shibusawa M Tsunoda Y Choh H Takata M Kusano M Implantation on the suture material and efficacy of povidone-iodine solution Eur Surg Res 1997, 29:473-480. 10.1159/000129559 9405970
14. Badia JM Whawell SA Scott-Coombes DM Abel PD Williamson RC Thompson JN Peritoneal and systemic cytokine response to laparotomy Br J Surg 1996, 83:347-348. 10.1002/bjs.1800830316 8665188
15. Leung KL Lai PB Ho RL Meng WC Yiu RY Lee JF Lau WY Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial Ann Surg 2000, 231:506-511. 1421025 10749610 10.1097/00000658-200004000-00008
16. Dinarello CA Biologic basis for interleukin-1 in disease Blood 1996, 87:2095-2147. 8630372
17. Voronov E Shouval DS Krelin Y Cagnano E Benharroch D Iwakura Y Dinarello CA Apte RN IL-1 is required for tumor invasiveness and angiogenesis Proc Natl Acad Sci USA 2003, 100:2645-2650. 151394 12598651 10.1073/ pnas.0437939100
18. Machado JC Pharoah P Sousa S Carvalho R Oliveira C Figueiredo C Amorim A Seruca R Caldas C Carneiro F Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma Gastroenterology 2001, 121:823-829. 10.1053/gast.2001.28000 11606496
19. Barber MD Powell JJ Lynch SF Fearon KC Ross JA A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer Br J Cancer 2000, 83:1443-1447. 10.1054/bjoc.2000.1479 11076651
20. Leung KL Lai PB Ho RL Meng WC Yiu RY Lee JF Lau WY Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial Ann Surg 2000, 231:506-511. 1421025 10749610 10.1097/00000658-200004000-00008
21. Da Costa ML Redmond HP Bouchier-Hayes DJ Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery J Surg Res 2001, 101:111-119. 10.1006/ jsre.2001.6250 11735264
22. Kim SH Milsom JW Gramlich TL Toddy SM Shore GI Okuda J Fazio VW Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer? Dis Colon Rectum 1998, 41:971-978. 10.1007/BF02237382 9715151
23. Edwards BK Brown ML Wingo PA Howe HL Ward E Ries LA Schrag D Jamison PM Jemal A Wu XC et al Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment J Natl Cancer Inst 2005, 97:1407-1427. 16204691
24. Cuschieri A Fayers P Fielding J Craven J Bancewicz J Joypaul V Cook P Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 1996, 347:995-999. 10.1016/S0140-6736(96)90144-0 8606613
25. Bonenkamp JJ Songun I Hermans J Sasako M Welvaart K Plukker JT van Elk P Obertop H Gouma DJ Taat CW et al Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 1995, 345:745-748. 10.1016/S0140-6736(95)90637-1 7891484
26. Wanebo HJ Kennedy BJ Winchester DP Fremgen A Stewart AK Gastric carcinoma: Does lymph node dissection alter survival? J Am Coll Surg 1996, 183:616-624. 8957465
27. Hermans J Bonenkamp JJ Boon MC Bunt AM Ohyama S Sasako M Velde Van de CJ Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials J Clin Oncol 1993, 11:1441-1447. 8336183
28. Ghaneh P Kawesha A Evans JD Neoptolemos JP Molecular prognostic markers in pancreatic cancer J Hepatobiliary Pancreat Surg 2002, 9:1-11. 10.1007/ s005340200000 12021893
29. Galland RB Saunders JH Mosley JG Darrell JH Prevention of wound infection in abdominal operations by peroperative antibiotics or povidone-iodine. A controlled trial Lancet 1977, 19(2):1043-1045. 10.1016/S0140-6736(77)91880-3